Navco Pharmaceuticals Inc (NAV.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in thousands)
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Operating Expenses | 85 | 6 | 78 | 17 |
| Operating Income | -85 | -6 | -78 | -17 |
| Pre-tax Income | -84 | -6 | -78 | -17 |
| Net Income Continuous | -84 | -6 | -78 | -17 |
| Net Income | $-84 | $-6 | $-78 | $-17 |
| EPS Basic Total Ops | -0.02 | 0.00 | -0.02 | 0.00 |
| EPS Basic Continuous Ops | -0.02 | 0.00 | -0.02 | N/A |
| EPS Diluted Total Ops | -0.02 | 0.00 | -0.02 | 0.00 |
| EPS Diluted Continuous Ops | -0.02 | 0.00 | -0.02 | N/A |
| EBITDA(a) | $-85 | $-6 | $-78 | $-17 |